Demographic, clinical and discharge care
| STEMI (n=390) | NSTEMI (n=981) | UA+chest pain of likely ischaemic origin (n=928) | All ACS (n=2299) | |
|---|---|---|---|---|
| Demographics and documented medical history before index admission* | ||||
| Mean age, years (SD) | 65 (14) | 71 (13) | 68 (13) | 69 (13) |
| Male | 283 (73) | 619 (63) | 586 (63) | 1488 (65) |
| Prior MI | 64 (16) | 330 (34) | 334 (36) | 728 (32) |
| Prior PCI | 44 (11) | 180 (18) | 308 (33) | 532 (23) |
| Prior CABG | 16 (4) | 129 (13) | 133 (14) | 278 (12) |
| History of hypertension | 209 (54) | 673 (69) | 676 (73) | 1558 (68) |
| History of hyperlipidaemia | 176 (45) | 571 (58) | 617 (66) | 1364 (59) |
| Diabetes | 69 (18) | 303 (31) | 288 (31) | 660 (29) |
| Prior PAD or TIA or stroke | 31 (8) | 197 (20) | 149 (16) | 377 (16) |
| Morbid obesity (≥35 kg/m2) | 21 (5) | 81 (8) | 77 (8) | 179 (8) |
| Other comorbidity† | 40 (10) | 219 (22) | 155 (17) | 414 (18) |
| Length of stay for index admission, median days (IQR) | 4.1 (2.9, 6.5) | 4.2 (2.9, 6.8) | 2.1 (1.1, 4.1) | 3.5 (2.0, 5.8) |
| Documented clinical measures during index admission* | ||||
| Total cholesterol, mean (SD) | 4.78 (1.2) | 4.68 (1.4) | 4.57 (1.3) | 4.67 (1.3) |
| ≥4.5 mmol/L | 179/306 (58) | 317/605 (52) | 215/438 (49) | 711/1349 (53) |
| LDL cholesterol, mean (SD) | 2.89 (1.0) | 2.74 (1.1) | 2.51 (1.2) | 2.7 (1.1) |
| ≥2.5 mmol/L | 174/265 (66) | 290/519 (56) | 155/326 (48) | 619/1110 (56) |
| Glucose, mean (SD) | 8.55 (5.5) | 9.40 (12.8) | 8.11 (8.8) | 8.74 (10.3) |
| ≥6.5 mmol/L | 204/324 (63) | 389/741 (52) | 261/665 (39) | 854/1730 (49) |
| Systolic blood pressure, mean (SD) | 136.1 (26.4) | 144.7 (28.0) | 144.4 (26.0) | 143.1 (27.1) |
| ≥140 mm Hg | 162/385 (42) | 541/973 (56) | 516/924 (56) | 1219/2282 (53) |
| Current smoker | 125 (32) | 174 (18) | 134 (14) | 433 (19) |
| Revascularisation during admission | 295 (76) | 414 (42) | 175 (19) | 884 (38) |
| GRACE risk score | 138 (31) | 135 (31) | 116 (28) | 128 (31) |
| Documented preventive care received during index admission* | ||||
| Smoking cessation advice/current smokers | 103/125 (82) | 118/174 (68) | 80/134 (60) | 301/433 (70) |
| Screening for depression | 50 (13) | 115 (12) | 63 (7) | 228 (10) |
| Dietary modification advice | 208 (53) | 408 (42) | 215 (23) | 831 (36) |
| Physical activity advice | 247 (63) | 491 (50) | 250 (27) | 988 (43) |
| Inpatient cardiac rehabilitation | 235 (60) | 470 (48) | 257 (28) | 962 (43) |
| Seen by Indigenous health worker/Indigenous‡ | 13/22 (59) | 27/51 (53) | 26/49 (53) | 66/122 (54) |
| Referral to outpatient cardiac rehabilitation | 277 (71) | 525 (54) | 263 (28) | 1065 (46) |
| Medications prescribed at discharge* | ||||
| Aspirin | 376 (96) | 860 (88) | 770 (83) | 2006 (87) |
| Other antiplatelet | 335 (86) | 696 (71) | 420 (45) | 1451 (63) |
| Statin/other lipid lowering therapy | 361 (93) | 843 (86) | 740 (80) | 1944 (85) |
| β-blocker | 319 (82) | 749 (76) | 572 (62) | 1640 (71) |
| ACEi or A2RB | 296 (76) | 649 (66) | 561 (60) | 1506 (65) |
| Diabetic drug§ | 62 (17) | 242 (27) | 231 (28) | 535 (23) |
| Antidepressant | 43 (12) | 124 (14) | 177 (22) | 344 (15) |
*n(%), unless otherwise specified.
†Other comorbidity includes—cancer, liver disease, dementia, renal impairment or on dialysis.
‡Includes all those documented as being of Aboriginal/Torres Strait/Maori/Pacific Island background.
§Diabetic drug includes metformin, insulin, and other diabetic drug.
A2RB, angiotensin II receptor blocker; ACEi, ACE inhibitor; ACS, acute coronary syndrome; CABG, coronary artery bypass graft surgery; GRACE, Global Registry of Acute Coronary Events; LDL, low density lipoprotein cholesterol; MI, myocardial infarction; NSTEMI, non-ST segment elevation myocardial infarction; PAD, peripheral arterial disease; PCI, percutaneous coronary intervention; SBP, systolic blood pressure; STEMI, ST segment elevation myocardial infarction; TC, total cholesterol; TIA, transient ischaemic attack; UA, unstable angina.